Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Sponsor: Beijing Friendship Hospital
Summary
Lymphoma-associated hemophagocytic lympohistiocytosis is a refractory immune disorder with high mortality. Early identification and diagnosis of lymphoma-associated HLH has become the key to improve the prognosis of lymphoma-associated HLH. Therefore, we conduct a multicenter, prospective, observational clinical study to explore the sensitivity and specificity of cytokines for the early diagnosis of lymphoma-associated HLH.
Official title: The Role of Cytokines in Early Diagnosis, Assessment of Response and Prognosis of Patients With Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
89
Start Date
2022-11-01
Completion Date
2025-12-31
Last Updated
2026-10-09
Healthy Volunteers
No
Interventions
cytokine
Peripheral blood samples were collected at diagnosis, 2 weeks after the first cycle of chemotherapy and 2 weeks after the second cycle of chemotherapy to monitor cytokine level changes.
Locations (1)
Zhao Wang
Beijing, Beijing Municipality, China